Thursday, December 27, 2012 2:37:40 PM
If you have any doubts this is all you need to ask yourself. We're talking about the freaking co-founder of Amgen, a $67 Billion company. He previously said: "I believe in MANF," said Dr. Rubinfeld, "I have reviewed a great number of technologies in my 45 year career in the biopharmaceutical field, and I believe that MANF could be one of the biggest successes that I have ever seen." And he's presenting on the potential for commercial opportunities of MANF at a conference in January. For doubters: Do you really think they're going to present bad data in front of a conference of VC and angel investors and big pharma companies that are paying $400 to attend?
Then ask yourself why another biotech firm in the same exact field with MJFF grants was compelled to challenge their patents and even stated that the patent protection is so broad that is causes "an undue burden on anyone trying to test MANF and any of its variants".
$28 Million market cap for all of this? Puhlease. This is a friggin freight train heading higher. Anyone trying to flip it for pennies will be very sorry when it runs to $0.40+ and they're left waiting for a dip. It's going to be a $100 Million+ company very soon.
My money is with the co-founder of Amgen...
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM